Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Cancer Immunol Res. 2015 Apr;3(4):313–319. doi: 10.1158/2326-6066.CIR-15-0041

Figure 2. Therapeutic Avenues to Increase Tumoral CD103+ DCs.

Figure 2

Schematic diagram of potential methods to increase the abundance of CD103/BDCA3+ DCs at the tumor in order to enhance antitumor T-cell immunity locally.